
Caprine serum is sourced from Australasia in view of that region's favourable Transmissible Spongioform Encephalopathy (TSE) profile.
Manufacturing takes place in the United Kingdom and Australia at cGMP. AIMSPRO is listed on the Export Only section of the Australian Therapeutic Goods Register and appropriate Certificates of Pharmaceutical product have been issued, including for North America and Europe.
|
|
5th Nov 2009 AIMSPRO receives US orphan-drug designation for ALS |
|
29th Sep 2009 Ceremben Permit Approved |
|
22nd Jul 2009 Patent granted by the OAPI |